Advertisement

Complex Cardiac Surgery Without Blood Transfusions: Lessons Learned from Managing Jehovah Witness Patients

  • Hiroto Kitahara
  • Takeyoshi Ota
  • Valluvan JeevanandamEmail author
Chapter
Part of the Difficult Decisions in Surgery: An Evidence-Based Approach book series (DDSURGERY)

Abstract

Jehovah’s Witnesses (JW) are well recognized for their refusal of blood products as part of their faith. Cardiac surgery is associated with relatively high demand for blood transfusion making it challenging to perform cardiac surgery in JW patients. The first case of cardiac surgery in a JW patient was reported in 1964. Since then, blood management strategies have evolved including preoperative optimization of hemoglobin level, new pharmacological agents, and improved cardiopulmonary bypass systems. Currently, cardiac surgery in JW patients including even high-risk complex cases can be safely performed with those blood management strategies. Recently clinical outcomes in cardiac surgery in JW patients have become comparable to those of non-JW patients in a selected patient group. There are many positive effects by avoiding blood transfusion such as risks of blood-transmitted infection. Therefore, the blood management strategies developed for JW patients would be beneficial to any cardiac surgery patients. In this chapter, current blood management strategies in cardiac surgery of JW patients will be discussed.

Keywords

Jehovah’s Witnesses Cardiac surgery Blood transfusion Bloodless surgery 

References

  1. 1.
    2017 year book of Jehovah’s witnesses. Warwick: Watchtower Bible and Tract Society of NY Inc; 2017.Google Scholar
  2. 2.
    Cooley DA, Crawford ES, Howell JF, Beall AC Jr. Open heart surgery in Jehovah’s Witnesses. Am J Cardiol. 1964;13:779–81.CrossRefGoogle Scholar
  3. 3.
    Zaorski JR, Hallman GL, Cooley DA. Open heart surgery for acquired heart disease in Jehovah’s Witnesses. A report of 42 operations. Am J Cardiol. 1972;29:186–9.CrossRefGoogle Scholar
  4. 4.
    Chiariello L, Sandiford FM, Cooley DA. Aortocoronary bypass in Jehovah’s Witnesses: results in 36 patients. Cardiovasc Dis. 1974;1:87–94.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Ott DA, Cooley DA. Cardiovascular surgery in Jehovah’s Witnesses. Report of 542 operations without blood transfusion. JAMA. 1977;238:1256–8.CrossRefGoogle Scholar
  6. 6.
    Tanaka A, Ota T, Uriel N, et al. Cardiovascular surgery in Jehovah’s Witness patients: the role of preoperative optimization. J Thorac Cardiovasc Surg. 2015;150:976–83.CrossRefGoogle Scholar
  7. 7.
    Marshall L, Krampl C, Vrtik M, et al. Short term outcomes after cardiac surgery in a Jehovah’s Witness population: an institutional experience. Heart Lung Circ. 2012;21:101–4.CrossRefGoogle Scholar
  8. 8.
    Emmert MY, Salzberg SP, Theusinger OM, et al. How good patient blood management leads to excellent outcomes in Jehovah’s witness patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg. 2011;12:183–8.CrossRefGoogle Scholar
  9. 9.
    McCartney S, Guinn N, Roberson R, et al. Jehovah’s Witnesses and cardiac surgery: a single institution’s experience. Transfusion. 2014;54:2745–52.CrossRefGoogle Scholar
  10. 10.
    Pompei E, Tursi V, Guzzi G, et al. Mid-term clinical outcomes in cardiac surgery of Jehovah’s witnesses. J Cardiovasc Med (Hagerstown). 2010;11:170–4.CrossRefGoogle Scholar
  11. 11.
    Vaislic CD, Dalibon N, Ponzio O, et al. Outcomes in cardiac surgery in 500 consecutive Jehovah’s Witness patients: 21 year experience. J Cardiothorac Surg. 2012;7:95.CrossRefGoogle Scholar
  12. 12.
    Moraca RJ, Wanamaker KM, Bailey SH, et al. Strategies and outcomes of cardiac surgery in Jehovah’s Witnesses. J Card Surg. 2011;26:135–43.CrossRefGoogle Scholar
  13. 13.
    Jassar AS, Ford PA, Haber HL, et al. Cardiac surgery in Jehovah’s Witness patients: ten-year experience. Ann Thorac Surg. 2012;93:19–25.CrossRefGoogle Scholar
  14. 14.
    Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who refuse transfusion after cardiac surgery. Arch Intern Med. 2012;172:1154–60.CrossRefGoogle Scholar
  15. 15.
    Guinn NR, Roberson RS, White W, et al. Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study. Transfusion. 2015;55:2791–8.CrossRefGoogle Scholar
  16. 16.
    El Azab SR, Vrakking R, Verhage G, et al. Safety of cardiac surgery without blood transfusion: a retrospective study in Jehovah’s Witness patients. Anaesthesia. 2010;65:348–52.CrossRefGoogle Scholar
  17. 17.
    Stamou SC, White T, Barnett S, et al. Comparisons of cardiac surgery outcomes in Jehovah’s versus Non-Jehovah’s Witnesses. Am J Cardiol. 2006;98:1223–5.CrossRefGoogle Scholar
  18. 18.
    Reyes G, Nuche JM, Sarrai A, et al. Bloodless cardiac surgery in Jehovah’s witnesses: outcomes compared with a control group. Rev Esp Cardiol. 2007;60:727–31.CrossRefGoogle Scholar
  19. 19.
    Vaislic C, Bical O, Farge C, et al. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah’s witnesses. Heart Surg Forum. 2003;6:307–10.PubMedGoogle Scholar
  20. 20.
    Bhaskar B, Jack RK, Mullany D, et al. Comparison of outcome in Jehovah’s Witness patients in cardiac surgery: an Australian experience. Heart Lung Circ. 2010;19:655–9.CrossRefGoogle Scholar
  21. 21.
    Marinakis S, Van der Linden P, Tortora R, et al. Outcomes from cardiac surgery in Jehovah’s witness patients: experience over twenty-one years. J Cardiothorac Surg. 2016;11:67.CrossRefGoogle Scholar
  22. 22.
    Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304:1568–75.CrossRefGoogle Scholar
  23. 23.
    Ranucci M, Baryshnikova E, Castelvecchio S, et al. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96:478–85.CrossRefGoogle Scholar
  24. 24.
    Miceli A, Romeo F, Glauber M, de Siena PM, et al. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg. 2014;9:137.CrossRefGoogle Scholar
  25. 25.
    Cladellas M, Farré N, Comín-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol. 2012;110:1021–6.CrossRefGoogle Scholar
  26. 26.
    Gaudiani VA, Mason DW. Preoperative erythropoietin in Jehovah’s Witnesses who require cardiac procedures. Ann Thorac Surg. 1991;51:823–4.CrossRefGoogle Scholar
  27. 27.
    Weltert L, Rondinelli B, Bello R, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55:1644–54.CrossRefGoogle Scholar
  28. 28.
    Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013;381:1855–65.CrossRefGoogle Scholar
  29. 29.
    Yu L, Gu T, Song E, et al. Fibrin sealant provides superior hemostasis for sternotomy compared with bone wax. Ann Thorac Surg. 2012;93:641–4.CrossRefGoogle Scholar
  30. 30.
    Henderson AM, Maryniak JK, Simpson JC. Cardiac surgery in Jehovah’s witnesses. A review of 36 cases. Anaesthesia. 1986;41:748–53.CrossRefGoogle Scholar
  31. 31.
    Mahmood S, Bilal H, Zaman M, et al. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? Interact Cardiovasc Thorac Surg. 2012;14:406–14.CrossRefGoogle Scholar
  32. 32.
    Rubens FD, Boodhwani M, Mesana T, et al. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116:I89–97.CrossRefGoogle Scholar
  33. 33.
    Boodhwani M, Hamilton A, de Varennes B, et al. A multicenter randomized controlled trial to assess the feasibility of testing modified ultrafiltration as a blood conservation technology in cardiac surgery. J Thorac Cardiovasc Surg. 2010;139:701–6.CrossRefGoogle Scholar
  34. 34.
    Richmond ME, Charette K, Chen JM, et al. The effect of cardiopulmonary bypass prime volume on the need for blood transfusion after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:1058–64.CrossRefGoogle Scholar
  35. 35.
    Fromes Y, Gaillard D, Ponzio O, et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg. 2002;22:527–33.CrossRefGoogle Scholar
  36. 36.
    John A, Bennett M, Lloyd C, et al. Overcoming challenges: the use of minimal extracorporeal circulation in Jehovah’s Witnesses undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2010;139:e122–3.CrossRefGoogle Scholar
  37. 37.
    Vasques F, Kinnunen EM, Pol M, et al. Outcome of Jehovah’s Witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies. Transfusion. 2016;56:2146–53.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Hiroto Kitahara
    • 1
  • Takeyoshi Ota
    • 1
  • Valluvan Jeevanandam
    • 1
    Email author
  1. 1.Department of Surgery, Section of Cardiac and Thoracic SurgeryThe University of ChicagoChicagoUSA

Personalised recommendations